Loading More Content
At its core, the legislation introduces a formal system of prioritisation in the allocation of NHS training posts. This applies both to the UK Foundation Programme and to specialty training.
The central principle is straightforward: Graduates from medical schools in the following countries are placed at the front of the queue for training posts:
This is not a complete exclusion of international applicants, and the system still allows all eligible candidates to apply. But it changes how offers are distributed, and places must now be allocated to UK graduates and the other defined priority groups before they are offered to other applicants for Foundation Programme posts.
For specialty training, the shift is slightly more complex, with the criteria for prioritisation being the same as the above, but with the addition of UK citizens that have an international medical degree also being included.
To understand the bill, it’s worth looking at the scale of the problem that is being addressed.
Over the past decade, competition for specialty training posts has increased dramatically. In 2019, there were around 12,000 applicants for 9,000 specialty training places. By 2026, this has risen to nearly 40,000 applicants competing for around 10,000 places.
Just as importantly, the composition of applicants has changed. There are now nearly twice as many overseas-trained applicants as UK-trained ones, which has led to a situation where UK graduates are sometimes unable to secure training posts and are instead moving abroad or leaving medicine altogether.
From the government’s perspective, this is both inefficient and unsustainable. Around £4 billion per year is spent training medical students in the UK, and the argument is that failing to retain those graduates within the NHS represents a loss of both talent and investment.
For students currently studying medicine in the UK, this means that there will be a considerably higher chance of getting a place at the end of training.
The bill is explicitly designed to ensure that UK graduates are not squeezed out of Foundation Programme posts. In previous years, whilst many UK graduates did secure placements, the rising competition created uncertainty and anxiety about whether that would always be the case. This legislation is intended to remove that uncertainty.
At the specialty level, the impact is more nuanced, and prioritisation could reduce competition ratios from around 4:1 to 2:1. This does not make training non-competitive, but it does make progression more predictable, which is crucial knowledge for both medical students and prospective applicants.
However, the number of training posts has not dramatically increased. The underlying constraint – limited capacity within the system – remains. What the bill does is redistribute access to those posts, rather than expanding them, tied to a longer-term goal of reducing reliance on international recruitment and addressing the global workforce shortages that are expected to reach 11 million by 2030.
For international medical graduates, the picture is more complicated.
The bill makes it clear that international applicants are still welcome in the NHS and can continue to apply for training posts. However, they are no longer competing on entirely equal footing with UK graduates, and priority is explicitly given to those trained within the UK system.
That said, the contribution of international doctors already working in the NHS will be recognised. From 2027 onwards, prioritisation criteria are expected to include measures like the number of years of NHS experience, rather than relying solely on immigration status.
In practise, this suggests a shift in the typical pathway for international doctors. Rather than moving directly into training, many may need to spend time in non-training roles within the NHS before becoming competitive applicants. The route remains open, but it is likely to be longer and less direct.
One of the more subtle implications of the bill concerns UK citizens who choose to study medicine outside the UK.
The legislation emphasises that prioritisation is based on where a doctor is trained, not where they are from. This means that a UK citizen who studies abroad will likely not receive the same priority as someone trained at a UK medical school.
Even students who are British citizens but study in countries such as Singapore or Malta are not automatically placed in the highest priority group. For prospective students considering this route, studying abroad is still a viable path into medicine, but it may no longer offer a straightforward return to UK training.
For UK medical students, the prioritisation bill should be reassuring. It strengthens your position within a system that has become increasingly competitive and uncertain, making it more likely that you will progress from medical school into training without prolonged delays.
For international graduates, the pathway into UK training is still open, but more complex. NHS experience is likely to become a key differentiator, and long-term planning will be more important than ever.
And for anyone considering studying medicine – whether in the UK or abroad – the bill does not close doors, it simply makes some routes more predictable and others less so.
Loading More Content